Delivery Order SPE2DB20D2104-SPE2DB25FMYFF
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BRILINTA 60 mg tablets. The firm-fixed-price contract, valued at $13,837.86, has an ultimate completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BRILINTA 60 mg tablets (60-count units) with a ceiling value of $2,852.60. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The contract involves no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,451.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $2,945.79 and a period of performance through March 5, 2025. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has an ultimate completion date of April 24, 2025 and a ceiling value of $2,687.32. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,890.12 to AmerisourceBergen Drug Corp for supply of Brilinta 60 mg tablets (60-count units) with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader federal pharmaceutical supply framework. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,044.86 and is classified as a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a $2,496.78 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a routine pharmaceutical supply transaction under the company's existing federal contracting relationships. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,157.10 contract is for the delivery of BRILINTA 90 MG TABLET 60S, a prescription medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,418.96 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the procurement of 4,566,162,380 units of the medication BRILINTA 90 MG TABLET 60S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range...